We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Detecting Hypermethylated Circulating Tumor DNA Using Digital PCR

App Note / Case Study  
Published: October 6, 2020
 
Detecting Hypermethylated Circulating Tumor DNA Using Digital PCR content piece image

Changes in the DNA methylation status of gene regulatory regions constitutes emerging biomarkers for several different cancers. This epigenetic change is biologically stable and is observed in circulating tumor DNA, meaning its presence can be exploited for early detection and noninvasive dynamic monitoring of tumor burden. In colorectal cancer hypermethylation of WNT inhibitory factor 1 (WIF1) and neuropeptide T (NPY) was found in 80% of metastatic patients and 44.7% of patients with Stage II/III disease.

Download this app note to discover:

  • If hypermethylated WIF1 and NPY can be used as a universal colorectal cancer marker
  • A digital PCR method for detecting hypermethylated WIF1 and NPY
Related Topic Pages
PCR
Liquid Biopsies
Cancer Diagnostics
Biomarkers
Cancer Genetics
Advertisement
Chosen for You
Dr. Khadijah A. Mitchell
Article

Cancer Research, Mentorship and Confidence in Your Competence With Dr. Khadijah A. Mitchell
A lab worker pipetting media into a cell culture dish.
Industry Insight

Recreating Organ-Specific Tumor Environments In Vitro
Nanopore Sequence Still
Whitepaper

Multiomic Sequencing Solutions To Revolutionize Human Disease Research
Advertisement
Advertisement
Decoratvive background images
Never miss a story
with the Breaking Science News daily newsletter